Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) dropped 4.4% during trading on Thursday . The stock traded as low as $6.02 and last traded at $6.08. Approximately 9,006 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 155,927 shares. The stock had previously closed at […]
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) saw a large drop in short interest in the month of August. As of August 31st, there was short interest totalling 1,300,000 shares, a drop of 29.7% from the August 15th total of 1,850,000 shares. Approximately 2.3% of the shares of the company are sold short. Based […]
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the […]
Oral presentation to include preclinical profile for ORX750, Centessa’s first orexin agonist development candidate for the treatment of narcolepsy and.
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) has earned an average rating of “Moderate Buy” from the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have issued a buy recommendation on […]